SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-002064
Filing Date
2021-04-06
Accepted
2021-04-06 16:30:09
Documents
2
Period of Report
2021-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 16535
2 PRESS RELEASE curr_ex991.htm EX-99.1 15006
  Complete submission text file 0001477932-21-002064.txt   32730
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 21809464
SIC: 2834 Pharmaceutical Preparations